This meeting took place in 2016
Here are the related meetings in 2020:
Cancer Stem Cells: Advances in Biology and Clinical Translation (T2)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Stem Cells and Cancer (C1)
Organizer(s) Austin Gurney, Connie J. Eaves and Jane E. Visvader
March 6—10, 2016
Beaver Run Resort • Breckenridge, CO USA
Discounted Abstract Deadline: Nov 4, 2015
Abstract Deadline: Dec 7, 2015
Scholarship Deadline: Nov 4, 2015
Discounted Registration Deadline: Jan 6, 2016
Sponsored by Bayer HealthCare Pharmaceuticals, BioLegend, Inc., Journal of Molecular Cell Biology (JMCB), OncoMed Pharmaceuticals, Inc. and Roche
Summary of Meeting:
Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses both tremendous challenges and tantalizing potential for our ability to successfully combat cancer. This Keystone Symposia meeting aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. One area of emphasis will be intercellular communication. Cellular context and microenvironment establish the tumor niche and shape the interaction of the tumor with the immune system. In addition, developmental signal transduction pathways such as Hippo, Notch and Wnt, frequently deregulated in cancer, increasingly offer tangible opportunities for therapeutic intervention. Another important area of emphasis will be efforts to better understand the mechanisms and importance of tumor heterogeneity. Techniques such as clonal analysis and barcoding are shedding important light on the interplay between tumor evolution, differentiation, miRNA control and epigenetics. This is an era of rapid progress in understanding cancer stem cell biology with great potential to benefit human health.
View Meeting Program
Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses both tremendous challenges and tantalizing potential for our ability to successfully combat cancer. This Keystone Symposia meeting aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. One area of emphasis will be intercellular communication. Cellular context and microenvironment establish the tumor niche and shape the interaction of the tumor with the immune system. In addition, developmental signal transduction pathways such as Hippo, Notch and Wnt, frequently deregulated in cancer, increasingly offer tangible opportunities for therapeutic intervention. Another important area of emphasis will be efforts to better understand the mechanisms and importance of tumor heterogeneity. Techniques such as clonal analysis and barcoding are shedding important light on the interplay between tumor evolution, differentiation, miRNA control and epigenetics. This is an era of rapid progress in understanding cancer stem cell biology with great potential to benefit human health.
View Meeting Program
Scholarships/Awards
Keystone Symposia Future of Science Fund Scholarship Recipients
Lauren Alicia Agro
University Health Network, Canada
Tyler Allen
North Carolina State University, USA
Nicholas M. Bohn
University of California, Los Angeles, USA
Talya L. Dayton
Massachusetts Institute of Technology, USA
Brittany Haugen
Memorial Sloan Kettering Cancer Center, USA
Takahiko Murayama
University of Tokyo, Japan
National Cancer Institute (NCI) Scholarship Recipients
Pablo Riera Freire
Dana-Farber Cancer Institute, USA
Marc Leushacke
ASTAR Institute of Medical Biology, Singapore
Robert Mathis
Jnana Therapeutics, USA
